BlackRock
CLOV icon

BlackRock’s Clover Health Investments CLOV Stock Holding History

BlackRock’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184M Buy
35,106,965
+3,266,453
+10% +$11.1M ﹤0.01% 1846
2026
Q1 		$56M Sell
31,840,512
-440,347
-1% -$955K ﹤0.01% 2436
2025
Q4 		$75.9M Buy
32,280,859
+1,885,917
+6% +$5.15M ﹤0.01% 2269
2025
Q3 		$93M Sell
30,394,942
-2,049
-0% -$5.85K ﹤0.01% 2140
2025
Q2 		$84.8M Buy
30,396,991
+20,029,317
+193% +$65.8M ﹤0.01% 2152
2025
Q1 		$37.2M Buy
10,367,674
+323,632
+3% +$1.3M ﹤0.01% 2540
2024
Q4 		$31.6M Buy
10,044,042
+417,514
+4% +$1.49M ﹤0.01% 2752
2024
Q3 		$27.1M Buy
9,626,528
+87,360
+0.9% +$200K ﹤0.01% 2838
2024
Q2 		$11.7M Sell
9,539,168
-1,041,490
-10% -$935K ﹤0.01% 3290
2024
Q1 		$8.4M Buy
10,580,658
+1,989,393
+23% +$1.81M ﹤0.01% 3437
2023
Q4 		$8.18M Buy
8,591,265
+161,225
+2% +$158K ﹤0.01% 3492
2023
Q3 		$9.1M Buy
8,430,040
+657,936
+8% +$783K ﹤0.01% 3389
2023
Q2 		$6.97M Sell
7,772,104
-18,831,002
-71% -$16.7M ﹤0.01% 3578
2023
Q1 		$22.5M Sell
26,603,106
-521,875
-2% -$571K ﹤0.01% 2921
2022
Q4 		$25.2M Buy
27,124,981
+1,237,746
+5% +$1.65M ﹤0.01% 2905
2022
Q3 		$44M Buy
25,887,235
+1,452,210
+6% +$3.8M ﹤0.01% 2537
2022
Q2 		$52.3M Buy
24,435,025
+18,753,936
+330% +$49.8M ﹤0.01% 2465
2022
Q1 		$20.2M Buy
5,681,089
+329,673
+6% +$956K ﹤0.01% 3172
2021
Q4 		$19.9M Buy
5,351,416
+1,865,164
+54% +$11.4M ﹤0.01% 3275
2021
Q3 		$25.8M Buy
3,486,252
+1,272,861
+58% +$10.9M ﹤0.01% 3112
2021
Q2 		$29.5M Buy
2,213,391
+134,492
+6% +$1.32M ﹤0.01% 3066
2021
Q1 		$15.7M Buy
+2,078,899
New +$23.5M ﹤0.01% 3311

Other funds holding CLOV

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock's CLOV Position: Q2 2026 in Review

BlackRock increased its Clover Health Investments (CLOV) stake by 10% in Q2 2026, buying an estimated $11.1M and bringing the position to 35,106,965 shares worth $184M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

BlackRock first reported a position in CLOV in Q1 2021 and has held it in 22 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • BlackRock held 35,106,965 shares of Clover Health Investments worth $184M as of Q2 2026.
  • BlackRock bought 3,266,453 Clover Health Investments shares in Q2 2026, an estimated $11.1M.
  • Clover Health Investments made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1846 holding.
  • BlackRock first reported a position in Clover Health Investments in Q1 2021 and has held it in 22 quarters since.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.